Search
Login 800.380.7652 +1.408.717.4955 Blog Blog

ShareVault Webinar Series

Webinars on business subjects relevant to our customers, delivered by thought leaders from our customer base.

Interested in presenting a Webinar? Click here

#40 —Microbiome:Hope or Hype? Moderator: Ravi Kiron, PhD, MBA | Managing Partner, BioPharm Strategy Advisors Inc.
Panelists:
Mark S. Wilson, MBA | President and CEO, MatriSys Bioscience, Inc.
About Colleen Cutcliffe, PhD | CEO and Co-Founder, Whole Biome
About Mohan Iyer, MBA | Chief Business Officer, Second Genome

Wednesday, March 29, 11:00am-12:15pm Pacific / 2:00-3:15pm Eastern
#39 —Web Panel Discussion: Non-Immuno-Oncology and Immuno-Oncology Partnering and Development: What's the Role of Non-IO in an IO World? Moderator: Linda Pullan, Ph.D, Pullan Consulting
Panelists:
Jeff Bockman, PhD | Vice President, Defined Health
Peter Sandor, MD, MBA | Vice President and Head Oncology Marketing Strategy, Astellas Pharma
Axel Hoos, MD, PhD | Vice President, Oncology R&D and Head of Immuno-Oncology, GlaxoSmithKline
Eric Haura, MD | Senior Member, Department of Thoracic Oncology, H. Lee Moffitt Cancer Center, Tampa, FL

Thursday, January 26, 11:00am-12:15pm Pacific / 2:00-3:15pm Eastern
#38 — Webinar: Part II: Maximizing M&A Value, Minimizing Risk: Business Process Integration
The second webinar in the series, "Maximizing M&A Value, Minimizing Surprises" (See Webinar 32 below for the first webinar in the series.)
Manish Dabas, M&A Senior Manager, and Elias Eliadis, Manager, of EY

Thursday, January 12, 11:00am-12:00pm Pacific / 2:00-3:00pm Eastern
#37 — Webinar: Financial Valuation Models for Life Science Companies - A More Detailed Explanation of Concepts
The second webinar in the series, "Must-Know Finance Concepts for Life Sciences Valuations" (See Webinar 33 below for the first webinar in the series.)
Jeff Karan and John Selig, Co-Founders and Managing Partners, Mavericks Capital

Thursday, October 13, 11:00am-12:00pm Pacific / 2:00-3:00pm Eastern
#36 — Web Panel Discussion: The Nuts & Bolts of Due Diligence in Biopharma Partnering Moderator:Linda Pullan, Ph.D, Pullan Consulting
Panelists:
James A. McCarthy, CLP, MBA, Corporate and Business Development, Alliance Management, CorpDev Ventures
Natalie Mirutenko, PhD, Transaction and Due Diligence Senior Director for the Center of External Innovation at Takeda
David L. Snitman, PhD, Partner, DL Snitman Inc and Former COO, Array BioPharma
Patrick Gattari, JD, Partner, McDonnell Boehnen Hulbert & Berghoff
Ann-Marie Costelloe, AFBPS, Chartered Organization Psychologist, Executive Consultant, Somerville Partners
William Gangi, MS, MBA | Director, Due Diligence Program Manager - Corporate Development, Shire

Wednesday, June 1, 11:00am-12:15pm Pacific / 2:00-3:15pm Eastern
#35 — Webinar: New FinTech Funding Alternatives for Life Science Companies Scott Jordan, CEO, S. Jordan Associates

Thursday, April 21, 11:00am-12:00pm Pacific / 2:00-3:00pm Eastern
#34 — Webinar: Selecting Suppliers to Help You Build Medical Devices Maren Nelson, M Nelson Consulting

Thursday, March 31, 11:00am-12:00pm Pacific / 2:00-3:00pm Eastern
#33 — Webinar: Must-Know Finance Concepts for Life Sciences Valuations Jeff Karan and John Selig, Co-Founders and Managing Partners, Mavericks Capital

Thursday, March 3, 11:00am-12:00pm Pacific / 2:00-3:00pm Eastern
#32 — Webinar: Maximizing M&A Value, Minimizing Surprises Elias Eliadis, Manager, EY LLP

Thursday, February 25, 11:00am-12:00pm Pacific / 2:00-3:00pm Eastern
#31 — Webinar: NIH Small Business Programs: What Biomedical Entrepreneurs Should Know Stephanie J. Fertig, MBA, Director, NINDS Small Business Programs, NIH
Kory Hallett, Ph.D, Small Business Innovation Research Development Center, National Cancer Institute, NIH

Tuesday, January 26, 11:00am-12:00pm Pacific / 2:00-3:00pm Eastern
#30 — Web Panel Discussion: Even More What's Hot in Immuno-Oncology Licensing Moderator: Linda Pullan, Ph.D, Pullan Consulting
Panelists:
Jeff Bockman, Ph.D, Defined Health
Ferran Prat, Ph.D, MD Anderson
Axel Hoos, MD, Ph.D, GlaxoSmithKline
Nate Sanburn, MS, Lilly

Thursday, December 10, 11:00am-12:30pm Pacific / 2:00-3:30pm Eastern
#29 — Webinar: Raising More Capital With a Regulation A+ Offering Anna Pinedo, Partner, Morrison & Foerster

Thursday, October 8, 2015, 11:00am-12:00pm Pacific / 2:00-3:00pm Eastern
#28 — Web Panel Discussion: What's Hot & What's Not in Immuno-Oncology Licensing Moderator: Linda Pullan, Ph.D, Pullan Consulting
Panelists:
Jeff Bockman, Ph.D, Defined Health
Ferran Prat, Ph.D, MD Anderson
Axel Hoos, MD, Ph.D, GlaxoSmithKline
Nate Sanburn, MS, Lilly

Tuesday, October 6, 11:00am-12:15pm Pacific / 2:00-3:00pm Eastern
#27 — Webinar: M&A Negotiations: Are You As Good As You Could Be?
Brian Moriarty, Former VP of HR, Mergers, Acquisitions and Divestitures, Hewlett-Packard

September 17, 2015
#26 — Web Panel: Best Practices for Sharing IP Rights in the Life Sciences Industry Moderator: Julie Watson, Special Counsel at Marshall Gerstein & Borun, LLP
Panelists:
Kate Murashige, Senior of Counsel, Morrison & Foerster
Dawn Matthews, CEO, ADMdx
Co-sponsored with Women in Bio, the Licensing Executives Society, and the BIO Investor Forum

September 2, 2015
#25 — Webinar: Essential Steps for Successful BioPharma Partnering Gautam Aggarwal, Partner, Triangle Insights Group
Co-sponsored with Triangle Insights Group, the Licensing Executives Society, and the Biotechnology Innovation Organization

July 16, 2015
#24 — Web Panel Discussion: What's Hot & What's Not in Gene Therapies for Rare Disorders
Moderator: Michael C. Rice, MS, MBA, Senior Consultant, Defined Health
Panelists:
Matthew Porteus, MD, Associate Professor of Pediatrics (Cancer Biology), Stanford University
Paul Gallagher, MBA, President, Compass Strategic Consulting
Stewart Abbot, Ph.D, Then Executive Director, Integrative Research at Celgene Cellular Therapeutics (CCT)

May 6, 2015
#23 — The Art & Science of High M&A Valuation
Maximum Value and Best Terms for Your Technology Company
David Stastny, Managing Director & Founder, Centaur Partners

January 21, 2015
#22 — Making Sense of New Patent Litigation Alternatives John Resek, Ph.D., JD, Co-Founder, Resek Liang & Frank LLC

October 23, 2014
#21 — What's Hot & What's Not in Oncology Licensing Moderator: Linda Pullan, Ph.D, Pullan Consulting
Panelists:
Jeff Bockman, Ph.D, Vice President, Defined Health
Paul Juniewicz, Vice President, Oncology Business Opportunities, Sanofi
Ferran Prat, Ph.D, VP of Strategic Industry Ventures, MD Anderson

September 18, 2014
#20 — The Seller's Guide to M&A HR Brian Moriarty, VP of Human Resources for Mergers, Acquisitions, Divestitures and Outsourcing (MADO), Hewlett-Packard
Thursday, July 17, 2014
#19 — The Seven Deadly Sins of M&A David Stastny, Managing Director & Founder of Centaur Partners, LLC
Wednesday, June 4, 2014
#18 — Overcoming SharePoint Security and External Sharing Challenges Don LaMure, Founder of the Silicon Valley SharePoint User Group
January 29, 2014
#17 — How to Win at the Partnering Game Linda Pullan, Pullan Consulting
October 23, 2013 and November 14, 2013
#16 — Biotech and Pharma Licensing Negotiations Linda Pullan, Pullan Consulting
March 26, 2013
#15 — Equity Crowdfunding for Life Sciences

Scott Jordan, Scott Jordan Associates
February 26, 2013
#14 — Valuation of Your Drug Candidate Linda Pullan, Pullan Consulting
January 24, 2013
#13 — Building a Successful Business Development and Licensing Strategy Carlos Velez, Ph.D., MBA, Lacerta Bio
December 6, 2012
#12 — Preserving Privilege in IP Transactions Russell E. Levine, P.C., Kirkland & Ellis
November 8, 2012
#11 — Building a Better Partnering Presentation

Linda Pullan, Pullan Consulting
October 11, 2012
#10 — ShareVault Best Practices: Protecting Intellectual Property in the Borderless Enterprise Stefan Adler, VP, H3 Consulting
May, 2012
#9 — ShareVault Best Practices: Planning for Your Exit Andy Thorson, former VP of Business Development, Varian Medical Systems
March, 2012
#8 — Getting Ready for a BioPharma Partnering Deal

Linda Pullan, Pullan Consulting
January, 2012
#7 — Maximizing Value For a Successful Acquisition (or How to Be a Hero to Your Shareholder) Kevin Scott, Director, Centaur Partners
November, 2011
#6 — Critical Steps For Driving Quality During e-Discovery Ed Lee, Deloitte Financial Advisory Services, LLP
July, 2011
#5 — Pharma/Biotech Needs a New Financing Model or We Are Doomed! Duane Roth, CEO, CONNECT
April, 2011
#4 — Navigating Later-Stage Venture Financing Complexities Tim Harris, esq., Partner at Morrison & Foerster
March, 2011
#3 — Doing Deals in Asia-Pacific Chuck Comey, esq., Partner at Morrison & Foerster
September, 2010
#2 — How to Position Your Company for an M&A Exit Brian Moriarty, Former VP Business Affairs, Sun Microsystems
July, 2010
#1 — How to Prepare for Your Company's M&A Transaction Michael Bates, former CFO, St. Francis Medical Technologies
May, 2010